Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer’s Disease and Type 2 Diabetes

María José Carranza-Naval(Biomedical Research and Innovation Institute of Cadiz), Mónica Garcı́a-Alloza(Universidad de Cádiz)
Frontiers in Aging Neuroscience
December 16, 2021
Cited by 51


Related Papers